Summary of Classification and Labelling
Notified classification and labelling
General Information
611-631-1 |
5-ethyl-2,8-dimethyl-5-[(propan-2-ylideneamino)oxy]-4,6-dioxa-3,7-diaza-5-silanona-2,7-diene |
58190-57-1 |
Notified classification and labelling according to CLP criteria
STOT RE 2 |
H373
(Red blood cells)
(oral)
|
H373
|
|
GHS08 Wng
|
|
|
|
|
14 |
|
View details
|
Number of Aggregated Notifications: 1